BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31926772)

  • 1. The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis.
    Yuan Y; Du Y; Wang L; Liu X
    Pathol Res Pract; 2020 Feb; 216(2):152796. PubMed ID: 31926772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis.
    Dou M; Zhou X; Fan Z; Ding X; Li L; Wang S; Xue W; Wang H; Suo Z; Deng X
    Cell Physiol Biochem; 2018; 45(6):2497-2505. PubMed ID: 29554659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.
    Pattani KM; Zhang Z; Demokan S; Glazer C; Loyo M; Goodman S; Sidransky D; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1093-103. PubMed ID: 20798208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
    Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
    Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.
    Pan J; Chen J; Zhang B; Chen X; Huang B; Zhuang J; Mo C; Qiu S
    PLoS One; 2013; 8(9):e75283. PubMed ID: 24073258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
    Chang Z; Zhou H; Liu Y
    Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
    Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
    J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
    J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
    Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
    Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis.
    Zhou X; Jiao D; Dou M; Chen J; Li Z; Li Y; Liu J; Han X
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):1939-1948. PubMed ID: 31263949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.
    Nørgaard M; Haldrup C; Storebjerg TM; Vestergaard EM; Wild PJ; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan.
    Hsiao PC; Liu MC; Chen LM; Tsai CY; Wang YT; Chen J; Hsu LS
    Chin J Physiol; 2008 Feb; 51(1):27-31. PubMed ID: 18551992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
    Cao Z; Wei L; Zhu W; Yao X
    Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
    Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
    Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.
    Lo KW; Tsang YS; Kwong J; To KF; Teo PM; Huang DP
    Int J Cancer; 2002 Apr; 98(5):651-5. PubMed ID: 11920632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis.
    Gao T; He B; Pan Y; Li R; Xu Y; Chen L; Nie Z; Gu L; Wang S
    PLoS One; 2013; 8(5):e62950. PubMed ID: 23675444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.